Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-016234
Filing Date
2011-03-22
Accepted
2011-03-22 09:37:39
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v214406_10k.htm 10-K 1246618
2 GRAPHIC pg11a.jpg GRAPHIC 7590
3 GRAPHIC pg11b.jpg GRAPHIC 5397
4 v214406_ex23-1.htm EX-23.1 3983
5 v214406_ex31-1.htm EX-31.1 14870
6 v214406_ex31-2.htm EX-31.2 14629
7 v214406_ex32-1.htm EX-32.1 8144
8 v214406_ex32-2.htm EX-32.2 8218
  Complete submission text file 0001144204-11-016234.txt   1315725
Mailing Address NO. 25 CHENGDE STREET DAWAI DISTRICT HARIN, HEILONGJIANG PROVINCE F4 150020
Business Address NO. 25 CHENGDE STREET DAWAI DISTRICT HARIN, HEILONGJIANG PROVINCE F4 150020 86 0451 88355530
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. (Filer) CIK: 0001484042 (see all company filings)

EIN.: 262816569 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-165684 | Film No.: 11702811
SIC: 2833 Medicinal Chemicals & Botanical Products